Dietary agents in cancer prevention: flavonoids and isoflavonoids.

[1]  A. Hara,et al.  Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. , 1995, Cancer research.

[2]  J. Potter,et al.  Vegetables, fruit and phytoestrogens as preventive agents. , 1996, IARC scientific publications.

[3]  R. Zhang,et al.  Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals. , 1997, Cancer letters.

[4]  C. V. van Kreijl,et al.  The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. , 1998, Cancer letters.

[5]  E. Riboli,et al.  Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. , 1998, Nutrition and cancer.

[6]  Lars Ernster.  [56] DT diaphorase , 1967 .

[7]  N. Day,et al.  DIET AND CANCER OF THE STOMACH: A CASE‐CONTROL STUDY IN GREECE , 1985, International journal of cancer.

[8]  C. Lamartiniere,et al.  Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity. , 1998, The American journal of clinical nutrition.

[9]  J. Nicolas,et al.  Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. , 1998, Cancer letters.

[10]  H. W. Chang,et al.  Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. , 1995, Life sciences.

[11]  A. Hara,et al.  Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. , 1997, Cancer research.

[12]  R. Mehta,et al.  Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. , 1998, The American journal of clinical nutrition.

[13]  R. Mehta,et al.  Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. , 1996, Anticancer research.

[14]  G. Hallmans,et al.  Soy and rye diets inhibit the development of Dunning R3327 prostatic adenocarcinoma in rats. , 1997, Cancer letters.

[15]  K. Pienta,et al.  An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. , 1994, Anticancer research.

[16]  W. Wang,et al.  Induction of NAD(P)H:quinone reductase by vitamins A, E and C in Colo205 colon cancer cells. , 1995, Cancer letters.

[17]  Peter C. H. Hollman,et al.  Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands , 1992 .

[18]  F. Shahidi,et al.  Phenolic antioxidants. , 1992, Critical reviews in food science and nutrition.

[19]  G. Wong,et al.  The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. , 1993, Nutrition and cancer.

[20]  R. Agarwal,et al.  A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. , 1998, Cancer research.

[21]  J. Pelling,et al.  Induction of p21/WAF1 and G1 cell‐cycle arrest by the chemopreventive agent apigenin , 1997, Molecular carcinogenesis.

[22]  G. Omenn.  What accounts for the association of vegetables and fruits with lower incidence of cancers and coronary heart disease? , 1995, Annals of Epidemiology.

[23]  M. Yano,et al.  Antiproliferative activity of flavonoids on several cancer cell lines. , 1999, Bioscience, biotechnology, and biochemistry.

[24]  R. Mohan,et al.  A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. , 1999, Cancer research.

[25]  P. Murphy,et al.  A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women. , 1996, The Journal of nutrition.

[26]  J. Lampe,et al.  Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. , 1997, The American journal of clinical nutrition.

[27]  R. Zhang,et al.  Individual and combinatory effects of soy isoflavones on the in vitro potentiation of lymphocyte activation. , 1997, Nutrition and cancer.

[28]  M. Fritsche,et al.  Flavonoids activate wild-type p53. , 1996, Oncogene.

[29]  D. Shutt,et al.  Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. , 1972, The Journal of endocrinology.

[30]  P. Talalay,et al.  Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Wong,et al.  Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. , 1991, Carcinogenesis.

[32]  H. Bui,et al.  Quantitative structure-activity relationship analysis of phenolic antioxidants. , 1999, Free radical biology & medicine.

[33]  T. Nikaido,et al.  Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. , 1992, Cancer research.

[34]  H. Ashida,et al.  Antimutagenicity of flavones and flavonols to heterocyclic amines by specific and strong inhibition of the cytochrome P450 1A family. , 1998, Bioscience, biotechnology, and biochemistry.

[35]  J. Lin,et al.  Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine. , 1994, Cancer letters.

[36]  T. Shibamoto,et al.  Human bioavailability of soy bean isoflavones: influences of diet, dose, time, and gut microflora. , 1998 .

[37]  J. Pezzuto,et al.  Inhibitory effect of munetone, an isoflavonoid, on 12-O-tetradecanoylphorbol 13-acetate-induced ornithine decarboxylase activity. , 1999, Cancer letters.

[38]  A. Papas.  Antioxidant Status, Diet, Nutrition, and Health , 1998 .

[39]  J. Gavin,et al.  Blood flow failure as a major determinant in the antitumor action of flavone acetic acid. , 1989, Journal of the National Cancer Institute.

[40]  P. Murphy,et al.  Bioavailability of soybean isoflavones depends upon gut microflora in women. , 1995, The Journal of nutrition.

[41]  J. W. Appelbaum.  The role of the immune system in the pathogenesis of cancer. , 1992, Seminars in oncology nursing.

[42]  A. Hara,et al.  Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. , 1996, Cancer research.

[43]  H. Adlercreutz,et al.  Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. , 1997, Cancer research.

[44]  G. Smith,et al.  Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. , 1972, The Biochemical journal.

[45]  N. Das,et al.  Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. , 1988, Biochemical medicine and metabolic biology.

[46]  J. Lampe,et al.  Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. , 1995, Journal of the American Dietetic Association.

[47]  S. Barnes,et al.  Introduction and satellite session at the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease. , 2002, The Journal of nutrition.

[48]  P. Hollman,et al.  Bioavailability of the dietary antioxidant flavonol quercetin in man. , 1997, Cancer letters.

[49]  R. A. King,et al.  Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. , 1998, The American journal of clinical nutrition.

[50]  L. Bourquin,et al.  Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. , 1998, The American journal of clinical nutrition.

[51]  R. Severson,et al.  A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. , 1989, Cancer research.

[52]  P. Talalay.  Mechanisms of induction of enzymes that protect against chemical carcinogenesis. , 1989, Advances in enzyme regulation.

[53]  Jeanette,et al.  C-ring cleavage of flavonoids by human intestinal bacteria , 1989, Applied and environmental microbiology.

[54]  D. C. Knight,et al.  A REVIEW OF THE CLINICAL EFFECTS OF PHYTOESTROGENS , 1996, Obstetrics and gynecology.

[55]  B. Hudson,et al.  Polyhydroxy flavonoid antioxidants for edible oils. structural criteria for activity , 1983 .

[56]  N Guthrie,et al.  Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. , 1996, Nutrition and cancer.

[57]  T. Mitsuoka.  Recent Trends in Research on Intestinal Flora , 1982 .

[58]  A. Aromaa,et al.  Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. , 1997, American journal of epidemiology.

[59]  J. Hendricks,et al.  Inhibition of aflatoxin B1 carcinogenesis in rainbow trout by flavone and indole compounds. , 1984, Carcinogenesis.

[60]  S H Kim,et al.  Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[61]  G. Gordon,et al.  Soy, its components, and cancer prevention: a review of the in vitro, animal, and human data. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[62]  J. Lampe,et al.  Urinary Equol Excretion with a Soy Challenge: Influence of Habitual Diet , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[63]  Plant-based diets and bone health: nutritional implications. , 1999, The American journal of clinical nutrition.

[64]  Yiwei Li,et al.  Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. , 1998, Nutrition and cancer.

[65]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[66]  H. Chen,et al.  Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. , 1998, Biochemical pharmacology.

[67]  D. N. Kirk,et al.  Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. , 1984, The American journal of clinical nutrition.

[68]  M. Goodman,et al.  Antioxidant property of dietary phenolic agents in a human LDL-oxidation ex vivo model: Interaction of protein binding activity , 1999 .

[69]  H. Wiseman.  The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens , 1999, Proceedings of the Nutrition Society.

[70]  E. Stein.  Lipid risk factors and atherosclerosis: what do we measure? , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[71]  G. Gordon,et al.  Induction of NAD(P)H:quinone reductase in human peripheral blood lymphocytes. , 1991, Carcinogenesis.

[72]  D. Ryan,et al.  Naturally-Occurring Estrogens in Plant Foodstuffs - A Review. , 1979, Journal of food protection.

[73]  L Bravo,et al.  Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. , 2009, Nutrition reviews.

[74]  M. Lean,et al.  Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. , 1998, The American journal of clinical nutrition.

[75]  J. Schenker,et al.  Short‐term Effects of Phytoestrogen‐rich Diet on Postmenopausal Women , 1997 .

[76]  J. Koeller,et al.  Phase I clinical and pharmacokinetic trial of flavone acetic acid. , 1991, Journal of the National Cancer Institute.

[77]  Jeffrey B. Harborne,et al.  The Flavonoids Advances in Research Since 1986 , 1993 .

[78]  M. Kuo,et al.  Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. , 1995, Biochemical and biophysical research communications.

[79]  Y. Tanaka,et al.  Proliferative response of mammary glandular tissue to formononetin. , 1995, Nutrition and cancer.

[80]  T. Sugimura,et al.  Effects of a Soybean Isoflavone Mixture on Carcinogenesis in Prostate and Seminal Vesicles of F344 Rats , 1999, Japanese journal of cancer research : Gann.

[81]  P. Hollman,et al.  Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.

[82]  E. Middleton,et al.  Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. , 1991, Cancer letters.

[83]  M. Gotoh,et al.  Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. , 1994, Life sciences.

[84]  J. Harborne.  General Procedures and Measurement of Total Phenolics , 1989 .

[85]  M. Iinuma,et al.  Studies on inhibitors of skin tumor promotion. XI. Inhibitory effects of flavonoids from Scutellaria baicalensis on Epstein-Barr virus activation and their anti-tumor-promoting activities. , 1992, Chemical & pharmaceutical bulletin.

[86]  H. Adlercreutz.  Phytoestrogens: epidemiology and a possible role in cancer protection. , 1995, Environmental health perspectives.

[87]  D. Birt.  Soybeans and cancer prevention: a complex food and a complex disease. , 2001, Advances in experimental medicine and biology.

[88]  M. Mcguire,et al.  Soybean isoflavones reduce experimental metastasis in mice. , 1999, The Journal of nutrition.

[89]  H. Adlercreutz,et al.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  N. Yamanaka,et al.  Prooxidant activity of caffeic acid, dietary non‐flavonoid phenolic acid, on Cu2+‐induced low density lipoprotein oxidation , 1997, FEBS letters.

[91]  Maurice E. Shils,et al.  Modern Nutrition in Health and Disease , 1965, Diabetes.

[92]  P. Hollman,et al.  CONTENT OF POTENTIALLY ANTICARCINOGENIC FLAVONOIDS OF TEA INFUSIONS, WINES, AND FRUIT JUICES , 1993 .

[93]  F. Persico,et al.  Non-selective inhibition of mammalian protein kinases by flavinoids in vitro. , 1987, Research communications in chemical pathology and pharmacology.

[94]  R. Nakaya.  Role of Bifidobacterium in Enteric Infection , 1984 .

[95]  S. Barnes,et al.  Genistein Alters the Ontogeny of Mammary Gland Development and Protects Against Chemically-Induced Mammary Cancer in Rats , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[96]  L. Tye,et al.  Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. , 1990, Cancer research.

[97]  D. Jerina,et al.  Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (±)-7β, 8α-dihydroxy-9α, 10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse , 1985 .

[98]  M. Piattelli,et al.  Flavonoids, coumarins, and cinnamic acids as antioxidants in a micellar system. Structure-activity relationship , 1996 .

[99]  B. Tudek,et al.  Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. , 1990, Mutation research.

[100]  D. Jerina,et al.  Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. , 1985, Carcinogenesis.

[101]  R. Miksicek.  Estrogenic Flavonoids: Structural Requirements for Biological Activity , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[102]  C. Riccardi,et al.  The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. , 1994, Leukemia research.

[103]  L. Koo.  Dietary habits and lung cancer risk among Chinese females in Hong Kong who never smoked. , 1988, Nutrition and cancer.

[104]  P. A. Thompson.  Plant Phenolics , 1965, Nature.

[105]  Yong Cheng,et al.  Diet and cancer of the stomach: A case‐control study in China , 1988, International journal of cancer.

[106]  K. Anderson,et al.  Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. , 1996, Nutrition and cancer.

[107]  W. Mazur,et al.  Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). , 1998, The Journal of nutrition.

[108]  K. Matsumoto,et al.  Genistein arrests cell cycle progression at G2-M. , 1993, Cancer research.

[109]  J. Pelling,et al.  Cell‐Cycle Arrest at G2/M and Growth Inhibition by Apigenin in Human Colon Carcinoma Cell Lines , 2000, Molecular carcinogenesis.

[110]  Jun Wang,et al.  Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. , 1998, Carcinogenesis.

[111]  B. Middleditch,et al.  Methyl p-hydroxyphenyllactate. An inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type-II binding sites. , 1988, The Journal of biological chemistry.

[112]  A. Lichtenstein.  Soy protein, isoflavones and cardiovascular disease risk. , 1998, The Journal of nutrition.

[113]  P. Murphy,et al.  Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. , 1999, The Journal of nutrition.

[114]  A. Kennedy,et al.  The evidence for soybean products as cancer preventive agents. , 1995, The Journal of nutrition.

[115]  T. Slaga,et al.  Effects of ellipticine, flavone, and 7,8-benzoflavone upon 7,12-dimethylbenz[a]anthracene, 7,14-dimethyldibenzo[a,h]anthracene and dibenzo[a,h]anthracene initiated skin tumors in mice. , 1985, Carcinogenesis.

[116]  X. Shu,et al.  Urinary excretion of isoflavonoids and the risk of breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[117]  E. Bresnick,et al.  Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. , 1986, Carcinogenesis.

[118]  J. Potter,et al.  Vegetables, fruit, and colon cancer in the Iowa Women's Health Study. , 1994, American journal of epidemiology.

[119]  E. Kyle,et al.  Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. , 1997, Molecular pharmacology.

[120]  Jeffrey B. Harborne,et al.  Methods in plant biochemistry , 1989 .

[121]  B. Li,et al.  The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. , 1996, Carcinogenesis.

[122]  V. Steele,et al.  Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. , 1994, Carcinogenesis.

[123]  Morris Pollard,et al.  Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. , 1997, Nutrition and cancer.

[124]  P. Murphy,et al.  Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver. , 1995, Nutrition and cancer.

[125]  K. Carroll,et al.  Inhibition of mammary cancer by citrus flavonoids. , 1998, Advances in experimental medicine and biology.

[126]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[127]  S. Davis,et al.  Phytoestrogens in Clinical Practice , 1998 .

[128]  End Dw,et al.  Non-selective inhibition of mammalian protein kinases by flavinoids in vitro. , 1987 .

[129]  J. Fahey,et al.  Chemoprotection against cancer by phase 2 enzyme induction. , 1995, Toxicology letters.

[130]  A. Collins,et al.  Antioxidant efficacy of phytoestrogens in chemical and biological model systems. , 1998, Archives of biochemistry and biophysics.

[131]  G. Cordell,et al.  Potential value of plants as sources of new antifertility agents I. , 1975, Journal of pharmaceutical sciences.

[132]  R. Watson.  Immunological enhancement by fat-soluble vitamins, minerals, and trace metals: a factor in cancer prevention. , 1986, Cancer detection and prevention.

[133]  R. Gryglewski,et al.  Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.

[134]  P. Hollman,et al.  Absorption, metabolism and health effects of dietary flavonoids in man. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[135]  W. Pierpoint.  Flavonoids in the human diet. , 1986, Progress in clinical and biological research.

[136]  L. F. Chasseaud,et al.  The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. , 1979, Advances in cancer research.

[137]  G. Blackburn,et al.  Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. , 1998, Cancer research.

[138]  B. Bohm.  The minor flavonoids , 1988 .

[139]  P. Rothberg,et al.  Influence of portein tyrosine phosphorylation on the experssion of the c‐myc oncogene in cancer of the large bowel , 1995, Journal of cellular biochemistry.

[140]  N. Sekar,et al.  Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. , 1994, Cancer letters.

[141]  J. L. Hess,et al.  Antioxidants in Higher Plants , 1993 .

[142]  P. Engstrom,et al.  Chemoprevention of cancer. , 1994, Current problems in cancer.

[143]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[144]  C. Falany,et al.  Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. , 1998, The American journal of clinical nutrition.

[145]  M. Nair,et al.  Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. , 1998, Archives of biochemistry and biophysics.

[146]  M. Pike,et al.  Soy intake and risk of breast cancer in Asians and Asian Americans. , 1998, The American journal of clinical nutrition.

[147]  H. Adlercreutz.  Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[148]  M. Lean,et al.  Absorption and excretion of conjugated flavonols, including quercetin-4'-O-beta-glucoside and isorhamnetin-4'-O-beta-glucoside by human volunteers after the consumption of onions. , 1998, Free radical research.

[149]  E. Feskens,et al.  Dietary flavonoids and cancer risk in the Zutphen Elderly Study. , 1994, Nutrition and cancer.

[150]  S. Haslam,et al.  Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. , 1998, Cancer research.

[151]  E. Huberman,et al.  Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. , 1990, Cancer research.

[152]  L. Wattenberg.  Inhibition of carcinogenesis by minor dietary constituents. , 1992, Cancer research.

[153]  W. Wang,et al.  Dietary soy protein is associated with reduced intestinal mucosal polyamine concentration in male Wistar rats. , 2000, The Journal of nutrition.

[154]  J. Erdman,et al.  Erratum: The role of soy in preventing and treating chronic disease. Proceedings of a Symposiums. Brussels, Belgium, September 15-19, 1996 (American Journal of Clinical Nutrition (1998) 68 (1329S-544S)) , 1999 .

[155]  G. Tedeschi,et al.  DT-diaphorase , 1995, The Journal of Biological Chemistry.

[156]  H. Wei,et al.  Effect of structurally related flavones/isoflavones on hydrogen peroxide production and oxidative DNA damage in phorbol ester-stimulated HL-60 cells. , 1997, Nutrition and cancer.

[157]  R. Mehta,et al.  Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. , 1995, Journal of natural products.

[158]  P. Murphy,et al.  Neither background diet nor type of soy food affects short-term isoflavone bioavailability in women. , 2000, The Journal of nutrition.

[159]  J. Cillard,et al.  Antioxidant activity of flavonoids and reactivity with peroxy radical , 1986 .

[160]  W. Wang,et al.  Enhancement of immune function in mice fed high doses of soy daidzein. , 1997, Nutrition and cancer.

[161]  G. Block,et al.  Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. , 1992, Nutrition and cancer.

[162]  C. Potten,et al.  Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro , 1999, British Journal of Cancer.

[163]  Z. Darżynkiewicz,et al.  Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. , 1992, Cancer research.

[164]  E. Parks,et al.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.

[165]  P. Hollman,et al.  The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. , 1999, Free radical research.

[166]  D. Hughes,et al.  Effects of dietary antioxidants on the immune function of middle-aged adults , 1999, Proceedings of the Nutrition Society.

[167]  E. Middleton,et al.  Effects of flavonoids on immune and inflammatory cell functions. , 1992, Biochemical pharmacology.

[168]  P. Murphy,et al.  Isoflavone content in commercial soybean foods , 1994 .

[169]  R J Miksicek,et al.  Commonly occurring plant flavonoids have estrogenic activity. , 1993, Molecular pharmacology.

[170]  M. Lebwohl,et al.  Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. , 1998, Carcinogenesis.

[171]  A. Uchida,et al.  Induction of apoptosis by quercetin: involvement of heat shock protein. , 1994, Cancer research.

[172]  P. Murphy,et al.  Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. , 1994, The Journal of nutrition.

[173]  E. Underwood,et al.  A specific breeding problem of sheep on subterranean clover pastures in Western Australia. , 1946, The British veterinary journal.

[174]  G. Cordell,et al.  Potential value of plants as sources of new antifertility agents II. , 1975, Journal of pharmaceutical sciences.

[175]  S. Kuo.  Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. , 1996, Cancer letters.

[176]  H. Adlercreutz,et al.  Dietary soybean may be antiestrogenic in male mice. , 1995, The Journal of nutrition.

[177]  Kaltreider Hb,et al.  Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid. , 1992 .

[178]  M. Clemens,et al.  Effect of Dietary Phytochemicals on Cancer Development , 2000 .

[179]  S. Barnes,et al.  Intestinal uptake and biliary excretion of the isoflavone genistein in rats. , 1997, The Journal of nutrition.

[180]  M B Katan,et al.  Bioavailability and health effects of dietary flavonols in man. , 1998, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[181]  A. Hara,et al.  Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. , 1997, Carcinogenesis.

[182]  S. Kuo,et al.  Dietary flavonoid and cancer prevention: evidence and potential mechanism. , 1997, Critical reviews in oncogenesis.

[183]  S. Renaud,et al.  Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.

[184]  T. Sakai,et al.  Inhibitory effect of quercetin on the synthesis of a possibly cell‐cycle‐related 17‐kDa protein, in human colon cancer cells , 1990, International journal of cancer.

[185]  G. Blackburn,et al.  Dietary immunomodulation: Beneficial effects on oncogenesis and tumor growth , 1990, Critical care medicine.

[186]  M. Veit,et al.  Urinary metabolites of flavonoids and hydroxycinnamic acids in humans after application of a crude extract from Equisetum arvense. , 1999, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[187]  J. Smyth,et al.  Progress in Clinical and Biological Research , 1979 .

[188]  R. A. King,et al.  Absorption and excretion of the soy isoflavone genistein in rats. , 1996, The Journal of nutrition.

[189]  H. Kal,et al.  Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid. , 1992, In vivo.

[190]  J. Cillard,et al.  Hydroxyl radical scavenging activity of flavonoids , 1987 .

[191]  W. Peters,et al.  Induction of rat hepatic and intestinal glutathione s-transferases and glutathione by dietary naturally-occurring anticarcinogens. , 1993, International journal of oncology.

[192]  E. Middleton.  Effect of plant flavonoids on immune and inflammatory cell function. , 1998, Advances in experimental medicine and biology.

[193]  P. Murphy,et al.  Urinary disposition of the soybean isoflavones daidzein, genistein and glycitein differs among humans with moderate fecal isoflavone degradation activity. , 1999, The Journal of nutrition.

[194]  L. Wattenberg.  Chemoprevention of cancer. , 1996, Preventive medicine.

[195]  S. Manenti,et al.  Flavonoids and the inhibition of PKC and PI 3-kinase. , 1999, General pharmacology.

[196]  L. Larocca,et al.  Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas , 1993, Cancer.

[197]  S. Barnes,et al.  Neonatal Genistein Chemoprevents Mammary Cancer , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[198]  K. Anderson,et al.  Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects. , 1995, Nutrition and cancer.

[199]  M. Friedman,et al.  Factors which facilitate inactivation of quercetin mutagenicity. , 1984, Advances in experimental medicine and biology.

[200]  P. Pour,et al.  Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. , 1997, Anticancer research.

[201]  M. Waring,et al.  Metabolites of dietary (soya) isoflavones in human urine. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[202]  M. Grant,et al.  The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. , 1998, Chemico-biological interactions.